Abstract: Objective To investigate the effects of hepatocyte growth factor(HGF)gene transfected bone marrow mesenchymal stem cells (MSCs)transplantation in pigs with chronic ischemic heart disease. Methods MSCs were isolated from pig bone marrow by density gradient centrifugation and adherent cell culture, purified, and determined by cellsurface antigens(CD34, CD44, CD71, Ⅷ factor and desmin). MSCs were transfected by adenovirus expressing hepatocyte growth factor(AdHGF), and the influence of HGF on the biological characteristics of MSCs was tested. The pig model of chronic myocardial ischemia was established by placing Ameroid ring inside the left circumflex coronary artery via leftthoracotomy. A total of 40 pigs were randomly divided into 5 groups (n=8) and were injected 5×106/ml MSCs+ 4×109 pfu 200 μl AdHGF (MSCs+ AdHGF group), 4×109 pfu 200 μl AdHGF (AdHGF group), 5×106/ml MSCs 200 μl(MSCs group),4×109 pfu 200 μl AdNull (AdNull group)and 1 ml saline(control group) into the ischemic myocardiumrespectively. Echocardiogram, digital subtraction angiography (DSA) of coronary artery, single photon emission computed tomography(SPECT) myocardial perfusion imaging and cardiomyocyte apoptosis were examined after 4 weeks. Results Positive CD44 and CD71 and negative CD34, Ⅷ factorand desmin were detected in MSCs by flow cytometer. HGF had a b influence on stimulating the proliferation and differentiation of MSCs. Echocardiogram examination showed that left ventricular end-diastolic volume(LVEDV),left ventricular ejection fraction(LVEF),fractional shortening(FS)of MSCs+ AdHGF group were significantly increased after treatment (P< 0.05). DSA detection showed that ischemic neovascularization of MSCs+ AdHGF group was significantly higher than those of AdHGF group and MSCs group (P< 0.05). SPECT showed that the left ventricular myocardium of MSCs+ AdHGF group appeared thickened,myocardial perfusion was significantly improved and the myocardial motion was significantly increased (P< 0.05). Vascular density of MSCs+ AdHGF group was significantly higher than those of AdHGF group and MSCs group by HE stain of myocardium [(39.4±1.2)/ HPF vs. (36.5±1.4)/ HPF and(34.5±1.7)/ HPF,P< 0.05]. Cardiomyocyte apoptosis rate of MSCs+ AdHGF group was significantly lower than those of AdHGF group and MSCs group by TUNEL stain (P< 0.05). Conclusion Combination transplantation can promote the angiogenesis of chronic ischemic myocardium, inhibit cardiomyocyte apoptosis and improve heart function in pigs with chronic ischemic heart disease. The effect of HGF gene transfected MSCs transplantation is better than that of MSCs or HGF transplantation alone.
目的:对无明显心血管病(CVD)临床症状者的高甘油三酯(TG)≥1.60 mmol/L低高密度脂蛋白胆固醇(HDL-C)≤1.18 mmol/L伴有活动平板运动试验(TET)心电图(ECG)阳性和TET ECG阴性的缺血性心脏病(IHD)的危险因素进行了对比观察。〖HTH〗方法:〖HT5”SS〗对无明显CVD临床症状的2900例受试者检测TG/HDL-C、其中伴有TET ECG阳性(缺血型ST-T改变)者500例和TET ECG阴性(不伴有缺血型ST-T改变)者2500例进行了5年对比观察, 预测其预后。〖HTH〗结果〖HTSS〗:在 5年随访的观察中高TG(≥1.60 mmol/L)/低HDL-C(≤1.18 mmmol/L)伴有TET ECG阳性者500例的IHD的发生(30例)率为6.00%;IHD死亡(14例)率为2.80%。而高TG/低HDL-C TET ECG 阴性者2500例的IHD发生(25例)率为2.80%, 死亡(8例)率为0.32%, Plt;0.001。表明高TG/低HDL-C伴有TET ECG阳性者是IHD的较大危险因素。结论:高TG/低H DL-C, 伴有TET ECG阳性对IHD者的死亡率的预测有重要意义, 提示二者指标共同作用对IHD者极为不利。
ObjectiveTo analyze the early results and risk factors of surgical revascularization for patients with ischemic heart disease and left ventricular dysfunction. Methodsclinical data of 318 patients with ischemic heart disease and left ventricular dysfunction with left ventricular ejection fraction (LVEF)≤50% who underwent coronary artery bypass grafting (cABG) from January 2003 to July 2013 was retrospectively reviewed. There were 266 males and 52 females with a mean age of 62.6±9.2 years (range 36 to 83). seventy-six patients underwent off-pump cABG (oPcAB) and 242 patients underwent conventional cABG. Fifteen patients underwent concomitant mitral valve repair or replacement. The patients who underwent left ventricular aneurysmectomy (LVA) were excluded from this study. Perioperative data were collected including the risk factors, echocardiographic results, morbidities and mortalities. The risk factors were analyzed with the endpoints of adverse events and mortalities to find the elements that influence the early results of the procedure. ResultsThe EuroscorE Ⅱ predicted operative mortality rate was 2.78±4.02% (range 1.00% to 45.00%) and actual mortality rate was 1.9% (6/318). Three of 6 patients died from low cardiac output syndrome. Totaladverse events rate was 47.2% (150/318) including prolonged ventilation (25.2%), low cardiac output syndrome (6.3%),ventricular arrhythmia (4.4%), acute renal dysfunction (4.1%), myocardial infarction (3.8%), cerebralvascular accident(2.8%), and re-exploration for bleeding (0.6%). Compared with those preoperatively, the LVEF was significantly improvedfrom 42.14%±5.94% to 45.64%±8.33% (t=6.084, P=0.000), and the left ventricular end diastolic dimension (LVEDD) wassignificantly reduced from 53.96±6.28 mm to 48.64±7.50 mm (t=-9.681, P=0.000) postoperatively. The logistic multiplevariables regression analysis showed perioperative intra-aortic balloon pump (IABP) implantation was mutual risk factorof prolonged ventilation and low cardiac output syndrome. ConclusionSurgical revascularization is an effective optionfor patients with ischemic heart disease and left ventricular dysfunction, demonstrated by improved LVEF and reducedLVEDD. Low cardiac output syndrome is the main cause of operative death. Perioperative IABP implantation is mutualrisk factor of prolonged ventilation and low cardiac output syndrome. Meticulous perioperative management plays a keyrole in satisfactory early results.